Cite
HARVARD Citation
Saito, Y. et al. (2020). Ribavirin induces hepatitis C virus genome mutations in chronic hepatitis patients who failed to respond to prior daclatasvir plus asunaprevir therapy. Journal of medical virology. 92 (2), pp. 210-218. [Online].